Right-Ace

Indication :

Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with: Manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascular disease) or Diabetes with at least one cardiovascular risk

Treatment of renal disease: Incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria, Manifest glomerular diabetic nephropathy as detined by macroproteinuria in patients with at least one cardiovascular risk factor Manifest glomerular non diabetic nephropathy as defined by. chanroteinuria 23 g/day

Treatment of symptomatic heart failure. Secondary prevention after acute myocardial infarction: reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started after 48 hours following acute myocardial infarction.

Composition :

Each tablet contains Ramipril 5 mg.

§Each tablet contains Ramipril 10 mg.